Showing results (291-300 of 5,165) with videos related to
Sort By:
Pageof 517
Current Oncology (Toronto, Ont.)|June 27, 2023
Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic LandscapeAndrew Nguyen, Alexander Nguyen, Oluwaferanmi T Dada, et al.Current Oncology (Toronto, Ont.)|June 27, 2023
Comparative Effectiveness of Chemotherapy Alone Versus Radiotherapy-Based Regimens in Locally Advanced Pancreatic Cancer: A Real-World Multicenter Analysis (PAULA-1)Alessandra Arcelli, Giuseppe Tarantino, Francesco Cellini, et al.Current Oncology (Toronto, Ont.)|June 27, 2023
Estimating the Associated Burden of Illness and Healthcare Utilization of Newly Diagnosed Patients Aged ≥65 with Mantle Cell Lymphoma (MCL) in Ontario, CanadaPeter Anglin, Julia Elia-Pacitti, Maria Eberg, et al.Current Oncology (Toronto, Ont.)|June 27, 2023
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic TherapyRebekah Rittberg, Bonnie Leung, Aria Shokoohi, et al.Current Oncology (Toronto, Ont.)|June 27, 2023
Biomarkers for Predicting Anti-Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck CancerKatsunori Tanaka, Hitoshi Hirakawa, Mikio Suzuki, et al.Current Oncology (Toronto, Ont.)|July 28, 2023
Nature-Based Virtual Reality Feasibility and Acceptability Pilot for Caregiver RespiteMohammed Owayrif Alanazi, Arienne Patano, Gary Bente, et al.Current Oncology (Toronto, Ont.)|July 28, 2023
Strategic Insight into the Combination Therapies for Metastatic Colorectal CancerYoshihito Kano, Mitsukuni Suenaga, Hiroyuki UetakeCurrent Oncology (Toronto, Ont.)|July 28, 2023
Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice GuidelineJames J Biagi, Roxanne Cosby, Mala Bahl, et al.Current Oncology (Toronto, Ont.)|July 28, 2023
Seminal Vesicle Treatment for Localized Prostate Cancer Treated with External Beam RadiotherapyTanner Steed, Nikki Chopra, Jihyun Yun, et al.Current Oncology (Toronto, Ont.)|July 28, 2023
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast CancerAlberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño, et al.Pageof 517